A Translational Study to Describe Asthma Patient Clinical Characteristics, Treatment Patterns, Biomarkers and to Identify Phenotypes and Endotypes associated with Differential Outcomes that may Support Future Development of Personalised Treatment Strategies in Chinese Population
Age 18 to 75 years of age
acceptable FEV1 (according to ATS and ERS)
compliance with study procedures All Asthma Cohorts
physician diagnosed Asthma greater or equal to 3 months prior to screening visit
history of alcohol or drug abuse within the past year
pregnant at time of an assessment
has an altered mental status at the time of informed consent
receipt marketed or investigational biologic(s) within 3 months or 5 half-lives prior to visit 1, whichever is longer